Research & Development

Combining CAR-M with checkpoint inhibitors such as PD-1 blockers creates a multi-pronged therapeutic strategy that addresses the biological complexity of solid tumors more effectively than monotherapy. The landscape of precision medicine is shifting as chimeric antigen receptor technologies evolve

The metabolic fitness of manufactured immune cells is a crucial metric, as exhausted cells lose their ability to persist once injected into a patient. Glioblastoma multiforme remains a relentless adversary in the field of neuro-oncology, characterized by its rapid progression and an almost

Clinical investigators are utilizing the follicle-stimulating hormone itself as a targeting mechanism to guide engineered T-cells directly to the FSHR-expressing ovarian tumor cells. This innovative approach, known as liraltagene autoleucel or lira-cel, represents a pivotal shift in how oncologists

Doctors emphasize the importance of patient transparency regarding peptide use to prevent potential drug interactions and to monitor for any adverse physiological reactions. This chemical sequence, known formally as Body Protection Compound 157, has transcended its origins in laboratory research to

Proposed revisions to human subject protections aim to ease the regulatory load on learning health systems while introducing more practical exemptions for low-risk research categories. The Department of Health and Human Services (DHHS) recently unveiled a comprehensive Unified Agenda that signals a

A landmark 300 billion won donation from the late Samsung Chairman Lee Kun-hee has established a vital safety net for pediatric cancer patients across South Korea. This massive philanthropic contribution arrived at a critical juncture for families facing the devastating reality of